Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Samudera Indonesia Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan Samudera Indonesia Tbk. diperdagangkan di Rp392 (kapitalisasi pasar 6,29 T, volume 24 jam 52,26 jt). Perbedaan utamanya: Samudera Indonesia Tbk. jauh lebih besar — sekitar 37,9× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Samudera Indonesia Tbk. lebih aktif diperdagangkan (52,26 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | SMDR | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 6,29 T |
Volume | 324 rb | 52,26 jt |
Lot | 3,24 rb | 522,58 rb |
Perputaran | 77,68 jt | 19,94 M |
Harga Rata-rata | 239,75 | 381,6 |
Nilai Transaksi | 77,68 jt | 19,94 M |
Harga Ekuilibrium Indikatif | 240 | 392 |
Volume Ekuilibrium Indikatif | 1 | 25,18 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Samudera Indonesia Tbk (the Company) was established on November 13, 1964 under the framework of the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970, based on notarial deed No. 33 of Soeleman Ardjasasmita, S.H. PT. Samudera Indonesia Tbk offers a full range of transportation services from feeder, tanker, offshore and land transportation for containers and heavy equipment to container depots and warehousing as well as freight forwarding services. In 1997, SSL, a subsidiary, listed on the Singapore Exchange Securities Trading Ltd.
Selengkapnya di halaman SMDR →